{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T18:56:46Z","timestamp":1779217006503,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Egypt Heart J"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction and objectives<\/jats:title>\n                    <jats:p>Perindopril-induced thrombocytopenia is a rare but potentially serious adverse drug reaction. It remains underrecognized in clinical practice, particularly in elderly patients with cardiovascular disease. This case highlights the importance of timely diagnosis and intervention in drug-induced hematologic complications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>A 73-year-old woman with a history of percutaneous coronary intervention presented with unstable angina. During hospitalization, she exhibited an acute and unexplained decline in platelet count a week after the initiation of perindopril. Infectious causes, autoimmune disorders, and bone marrow dysfunction were systematically excluded. A medication review revealed recent perindopril initiation, and its discontinuation led to progressive platelet recovery. The strong temporal relationship confirmed perindopril-induced thrombocytopenia as the likely etiology (Table 1).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The immune-mediated destruction of platelets is proposed as the underlying mechanism, similar to other drug-induced thrombocytopenias. This case underscores the importance of systematic diagnostic evaluation, routine hematologic monitoring, and pharmacovigilance in patients receiving angiotensin-converting enzyme inhibitors. Alternative antihypertensive strategies, such as angiotensin receptor blockers, may be preferable in susceptible individuals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Perindopril-induced thrombocytopenia should be considered in patients presenting with unexplained platelet decline. Early recognition, drug discontinuation, and close monitoring are crucial in preventing complications. Further research is needed to refine diagnostic criteria and develop safer prescribing guidelines.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s43044-026-00737-4","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:55:34Z","timestamp":1777370134000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacovigilance and clinical insights into perindopril-induced thrombocytopenia: a case report of diagnostic challenges and therapeutic alternatives"],"prefix":"10.1186","volume":"78","author":[{"given":"Mochamad Faishal","family":"Riza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Sudanawidjaja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald Torang Marsahala","family":"Panggabean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isnaini","family":"Isnaini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lely Puspita Candra","family":"Dewi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrianus","family":"Oktovianto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deo","family":"Idarto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent Aurelius","family":"Gonaldy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alamanda","family":"Sofania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marselina","family":"Marselina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"issue":"7","key":"737_CR1","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14740338.2023.2282582","volume":"23","author":"R Alloush","year":"2023","unstructured":"Alloush R, Lint JAv, Marum RJv, Hermens WW, Jessurun NT (2023) Hospital Registration of Adverse Drug Reactions in Electronic Health Records: Importance and Contribution to Pharmacovigilance. Exp Opin Drug Saf 23(7):925\u2013935. https:\/\/doi.org\/10.1080\/14740338.2023.2282582","journal-title":"Exp Opin Drug Saf"},{"issue":"6","key":"737_CR2","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/j.1538-7836.2009.03360.x","volume":"7","author":"RH Aster","year":"2009","unstructured":"Aster RH, Curtis BR, McFarland JG, Bougie DW (2009) Drug-Induced immune thrombocytopenia: Pathogenesis, diagnosis, and management. J Thromb Haemost 7(6):911\u2013918. https:\/\/doi.org\/10.1111\/j.1538-7836.2009.03360.x","journal-title":"J Thromb Haemost"},{"key":"737_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.839215","author":"M-S Bang","year":"2022","unstructured":"Bang M-S, Kim C, Kim D, Yun NR (2022) Effective Drugs Against Severe Fever With Thrombocytopenia Syndrome Virus in an in Vitro Model. Front Med. https:\/\/doi.org\/10.3389\/fmed.2022.839215","journal-title":"Front Med"},{"issue":"0304","key":"737_CR4","doi-asserted-by":"publisher","first-page":"w20400","DOI":"10.4414\/smw.2021.20400","volume":"151","author":"S Banholzer","year":"2021","unstructured":"Banholzer S, Dunkelmann L, Haschke M, Derungs A, Exadaktylos AK, Kr\u00e4henb\u00fchl S, Liakoni E (2021) Retrospective Analysis of Adverse Drug Reactions Leading to Short-Term Emergency Hospital Readmission. Swiss Med Wkly 151(0304):w20400. https:\/\/doi.org\/10.4414\/smw.2021.20400","journal-title":"Swiss Med Wkly"},{"issue":"3","key":"737_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.4103\/2452-2473.324236","volume":"21","author":"T \u00c7elik","year":"2021","unstructured":"\u00c7elik T, K\u00f6se A, Arslan ED, Y\u0131lmaz F (2021) Perindopril\/amlodipine-induced thrombotic microangiopathy: A case report. Turkish J Emerg Med 21(3):134\u2013137. https:\/\/doi.org\/10.4103\/2452-2473.324236","journal-title":"Turkish J Emerg Med"},{"issue":"3","key":"737_CR6","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1161\/HYPERTENSIONAHA.120.16667","volume":"78","author":"R Chen","year":"2021","unstructured":"Chen R, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, Pratt N, Reich CG, Madigan D, Hripcsak G, Ryan PB (2021) Comparative first-line effectiveness and safety of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: A multinational cohort study. Hypertension 78(3):591\u2013603. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.120.16667","journal-title":"Hypertension"},{"key":"737_CR7","doi-asserted-by":"publisher","DOI":"10.12890\/2020_002042","author":"AC D\u00fclger","year":"2020","unstructured":"D\u00fclger AC, Yakar\u0131\u015f\u0131k M, Uzun Y, \u015eahin AM (2020) Treatment of Crimean-Congo Haemorrhagic Fever by Favipiravir in a Patient With Novel Coronavirus Co-Infection. European J Case Rep Intern Medicine LATEST ONLINE. https:\/\/doi.org\/10.12890\/2020_002042","journal-title":"European J Case Rep Intern Medicine LATEST ONLINE"},{"issue":"2","key":"737_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/14740338.2018.1397129","volume":"17","author":"WJ Elliott","year":"2017","unstructured":"Elliott WJ, Bistrika EA (2017) Perindopril Arginine and Amlodipine Besylate for Hypertension: A Safety Evaluation. Exp Opin Drug Saf 17(2):207\u2013216. https:\/\/doi.org\/10.1080\/14740338.2018.1397129","journal-title":"Exp Opin Drug Saf"},{"issue":"2","key":"737_CR9","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s00228-011-1105-5","volume":"68","author":"CC Franz","year":"2011","unstructured":"Franz CC, Egger SS, Born C, Bravo AER, Kr\u00e4henb\u00fchl S (2011) Potential Drug-Drug Interactions and Adverse Drug Reactions in Patients With Liver Cirrhosis. Eur J Clin Pharmacol 68(2):179\u2013188. https:\/\/doi.org\/10.1007\/s00228-011-1105-5","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"737_CR10","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00228-011-1184-3","volume":"68","author":"E Garbe","year":"2011","unstructured":"Garbe E, Andersohn F, Bronder E, Salama A, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Sp\u00e4th-Schwalbe E, Gr\u00fcneisen A, Meyer O, Kurtal H (2011) Drug-Induced Immune Thrombocytopaenia: Results From the Berlin Case\u2013Control Surveillance Study. Eur J Clin Pharmacol 68(5):821\u2013832. https:\/\/doi.org\/10.1007\/s00228-011-1184-3","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"737_CR11","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1182\/asheducation-2009.1.153","volume":"2009","author":"JN George","year":"2009","unstructured":"George JN, Aster RH (2009) Drug-induced thrombocytopenia: Pathogenesis, evaluation, and management. Hematology 2009(1):153\u2013158. https:\/\/doi.org\/10.1182\/asheducation-2009.1.153","journal-title":"Hematology"},{"key":"737_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-024-00622-7","author":"M-C Glodeanu","year":"2024","unstructured":"Glodeanu M-C, Mutruc V, Apetrei C-M, Ursaru M, \u0218orodoc L, Lionte C (2024) Unprovoked Venous Thromboembolism Recurrence and Arterial Embolism Revealing Lung Cancer: A Case Report. Thromb J. https:\/\/doi.org\/10.1186\/s12959-024-00622-7","journal-title":"Thromb J"},{"issue":"12","key":"737_CR13","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1002\/ajh.27104","volume":"98","author":"S Khan","year":"2023","unstructured":"Khan S, George JN, Nusrat S (2023) Drug-induced thrombotic microangiopathy and thrombotic thrombocytopenic purpura: A systematic review, 2018\u20132023. Am J Hematol 98(12):E373\u2013E375. https:\/\/doi.org\/10.1002\/ajh.27104","journal-title":"Am J Hematol"},{"key":"737_CR14","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2021.2283","author":"E Milan","year":"2021","unstructured":"Milan E, Miceli P, Sernicola A, Finotto S, Marino D, Alaibac M (2021) Complete Remission of Primary Cutaneous Anaplastic Large Cell Lymphoma After a Short Course of Brentuximab Vedotin. Mol Clin Oncol. https:\/\/doi.org\/10.3892\/mco.2021.2283","journal-title":"Mol Clin Oncol"},{"issue":"2","key":"737_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s40264-015-0359-8","volume":"39","author":"C Njuguna","year":"2015","unstructured":"Njuguna C, Stewart A, Mouton JP, Blockman M, Maartens G, Swart A, Chisholm B, Jones J, Dheda M, Igumbor E, Cohen K (2015) Adverse Drug Reactions Reported to a National HIV &Amp Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of Reports. Drug Saf 39(2):159\u2013169. https:\/\/doi.org\/10.1007\/s40264-015-0359-8","journal-title":"Drug Saf"},{"issue":"1","key":"737_CR16","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4103\/2452-2473.301915","volume":"21","author":"V Peri\u0161a","year":"2021","unstructured":"Peri\u0161a V, Laslo D, Mari\u010di\u0107 L, Zibar L (2021) Perindopril\/Amlodipine-Induced Thrombotic Microangiopathy. Turkish J Emerg Med 21(1):38\u201341. https:\/\/doi.org\/10.4103\/2452-2473.301915","journal-title":"Turkish J Emerg Med"},{"key":"737_CR17","doi-asserted-by":"publisher","DOI":"10.1177\/1179547618781090","author":"L Pincet","year":"2018","unstructured":"Pincet L, Gorostidi F (2018) Graves Disease Causing Pancytopenia: Case Report and Literature Review. Clin Med Insights Case Rep. https:\/\/doi.org\/10.1177\/1179547618781090","journal-title":"Clin Med Insights Case Rep"},{"key":"737_CR18","doi-asserted-by":"publisher","DOI":"10.1097\/jcp.0000000000001798","author":"GD Salvo","year":"2023","unstructured":"Salvo GD, Porceddu G, Perotti C, Maina G, Rosso G (2023) Prevalence and Correlates of Serotonin Syndrome in Real-World Inpatients. J Clin Psychopharmacol. https:\/\/doi.org\/10.1097\/jcp.0000000000001798","journal-title":"J Clin Psychopharmacol"},{"key":"737_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-1-126","author":"J Silvestre","year":"2007","unstructured":"Silvestre J, Carvalho S, Mendes V, Coelho L, Tapadinhas C, Ferreira P, P\u00f3voa P, Ceia F (2007) Metformin-Induced Lactic Acidosis: A Case Series. J Med Case Rep. https:\/\/doi.org\/10.1186\/1752-1947-1-126","journal-title":"J Med Case Rep"},{"key":"737_CR20","doi-asserted-by":"crossref","unstructured":"Soucy-Gigu\u00e8re M-C, Turgeon PY, S\u00e9n\u00e9chal M (2019) What Cardiologists Should Know About Essential Thrombocythemia and Acute Myocardial Infarction: Report of Two Cases and Advanced Heart Failure Therapies Considerations","DOI":"10.2147\/IMCRJ.S217568"},{"issue":"26","key":"737_CR21","doi-asserted-by":"publisher","first-page":"e11206","DOI":"10.1097\/md.0000000000011206","volume":"97","author":"X Wang","year":"2018","unstructured":"Wang X, Zhang S, Li L, Hua J, Zhu L, Li L, Zhang G (2018) Ticagrelor-Induced Thrombotic Thrombocytopenic Purpura. Medicine 97(26):e11206. https:\/\/doi.org\/10.1097\/md.0000000000011206","journal-title":"Medicine"},{"issue":"2","key":"737_CR22","doi-asserted-by":"publisher","first-page":"e001322","DOI":"10.1136\/jitc-2020-001322","volume":"8","author":"DC Ziogas","year":"2020","unstructured":"Ziogas DC, Gkoufa A, Cholongitas \u0395, Diamantopoulos P, Anastasopoulou A, Ascierto PA, Gogas H (2020) When Steroids Are Not Enough in Immune-Related Hepatitis: Current Clinical Challenges Discussed on the Basis of a Case Report. J Immunother Cancer 8(2):e001322. https:\/\/doi.org\/10.1136\/jitc-2020-001322","journal-title":"J Immunother Cancer"}],"container-title":["The Egyptian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43044-026-00737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43044-026-00737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:55:38Z","timestamp":1777370138000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43044-026-00737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["737"],"URL":"https:\/\/doi.org\/10.1186\/s43044-026-00737-4","relation":{},"ISSN":["2090-911X"],"issn-type":[{"value":"2090-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient states its willingness to participate in this study by agreeing to our informed consent that states our requests to publish the patient case including the laboratory results.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent to publish has been obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27"}}